Assessing Patient Satisfaction and Confidence After Use of Educational Video to Augment Surgical Consent for Thyroid Surgery
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Thomas Jefferson University
- Study ID
- NCT06918223
- Status
- Recruiting
Conditions
- Thyroid Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Thyroid Informed Surgical Consent Augmenting Video (TISCAV) — BEHAVIORALParticipants randomized to the intervention group will receive a surgeon-created Thyroid Informed Surgical Consent Augmenting Video (TISCAV). This 8-minute video includes animated visuals and a surgeon voiceover explaining thyroid anatomy, surgical options (lobectomy vs. total thyroidectomy), risks, benefits, and expectations. The TISCAV was designed and reviewed by an endocrine surgery team to improve patient comprehension, confidence, satisfaction, and reduce decision regret compared to standard verbal consent alone.
- Standard Consent — BEHAVIORALParticipants receiving the Standard Consent intervention will undergo the routine informed consent process for thyroid surgery provided by their surgeon. This process includes a verbal discussion covering thyroidectomy procedure details, potential risks and complications, benefits, alternatives such as active surveillance, and an opportunity to ask questions.
Study Details
This study looks at how a short educational video can help people better understand thyroid surgery. Patients who have thyroid nodules and need surgery will be part of the study. Some patients will get the usual information from their doctor, while others will also watch a video that explains the surgery in a simple and clear way. The study will check if the video helps patients feel more confident about their decision, lowers anxiety, and helps them remember important information about their surgery. Patients will answer surveys before surgery, after surgery, and 3 months later.
Key Dates
- Start date
- Nov 10, 2023
- Status verified
- Apr 2025
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Intervention: TISCAV
- Placebo Comparator: Control: Standard Consent
Primary Outcome Measure
Patient knowledge score using a 10-item internally validated Thyroid Surgery Knowledge Assessment [ Time Frame: Immediately after study enrollment (pre-consent) and immediately following the surgical consent process (post-consent) ]
Central Contacts
- Annie Moroco Assistant Professor, MD215-955-6826
- Hani Research Fellow, BS3216091134
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 |
Find similar trials in Philadelphia, PA
Related Studies
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California
- A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsPHASE1 · Recruiting · Pfizer · Birmingham, Alabama
- Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TCPHASE2 · Recruiting · Massachusetts General Hospital · Washington D.C., District of Columbia
- DESTINY-PANTUMOUR04Recruiting · AstraZeneca · Birmingham, Alabama